UNSPSC 51291506: Deximafen

This classification denotes an antidepressant agent with the molecular formula C11H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1V5135S169, chemically known as 1h-imidazo(1,2-a)imidazole, 2,3,5,6-tetrahydro-3-phenyl-, ( )- but generally known as deximafen, which bears US NIH Compound Identifier 163316. European Medicines Agency schedules Deximafen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07031MIG.

UNSPSC 51291506 Deximafen is a Commodity code tracking pharmaceutical products for emergency medical response and overdose reversal, though recent state and local solicitations show activity centered on naloxone acquisition and drug deactivation systems rather than deximafen specifically. Seminole County, Florida released a competitive IFB in mid-2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems, reflecting the code's application to opioid crisis intervention supplies. Issuing bodies under this code span county health departments and community health initiatives, with procurement structured around fixed-fee, quarterly-delivery arrangements and standard compliance requirements including E-Verify authorization, workers' compensation coverage, and drug-free workplace certification. The contract model includes an initial two-year term with a one-year renewal option and a three-month probationary termination period.

Recent activity appears concentrated in Florida. Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, represents the only recent state and local opportunity on record under this code; the solicitation requested electronic bid submission through the county's e-Procurement Portal with all shipping and delivery costs included in vendor proposals. While the procurement does not specify set-aside designations for disadvantaged enterprises, potential FEMA funding introduces federal compliance overlays including Clean Air Act and Federal Water Pollution Control Act adherence. The mismatch between the code name (deximafen) and the actual procurement (naloxone and drug deactivation systems) suggests the taxonomy application may reflect a broader pharmaceutical-intervention category or a classification variance at the county level.